Literature DB >> 21912406

Diagnosis and treatment of neurocysticercosis.

Theodore E Nash1, Hector H Garcia.   

Abstract

Neurocysticercosis is a parasitic disease caused by the larval (cystic) form of the pork cestode tapeworm, Taenia solium, and is a major cause of acquired seizures and epilepsy worldwide. Development of sensitive and specific diagnostic methods, particularly CT and MRI, has revolutionized our knowledge of the burden of cysticercosis infection and disease, and has led to the development of effective antihelminthic treatments for neurocysticercosis. The importance of calcified granulomas with perilesional edema as foci of seizures and epilepsy in populations where neurocysticercosis is endemic is newly recognized, and indicates that treatment with anti-inflammatory agents could have a role in controlling or preventing epilepsy in these patients. Importantly, neurocysticercosis is one of the few diseases that could potentially be controlled or eliminated-an accomplishment that would prevent millions of cases of epilepsy. This Review examines the rationale for treatment of neurocysticercosis and highlights the essential role of inflammation in the pathogenesis of disease, the exacerbation of symptoms that occurs as a result of antihelminthic treatment, and the limitations of current antihelminthic and anti-inflammatory treatments.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21912406      PMCID: PMC3350327          DOI: 10.1038/nrneurol.2011.135

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


  107 in total

1.  Validation of diagnostic criteria for solitary cerebral cysticercus granuloma in patients presenting with seizures.

Authors:  V Rajshekhar; M J Chandy
Journal:  Acta Neurol Scand       Date:  1997-08       Impact factor: 3.209

2.  Medical treatment of cysticercosis--effective.

Authors:  O H del Brutto
Journal:  Arch Neurol       Date:  1995-01

3.  Prevalence, incidence, and etiology of epilepsies in rural Honduras: the Salamá Study.

Authors:  Marco T Medina; Reyna M Durón; Lisandro Martínez; Juan Ramón Osorio; Ana L Estrada; Concepción Zúniga; Dora Cartagena; Julianne S Collins; Kenton R Holden
Journal:  Epilepsia       Date:  2005-01       Impact factor: 5.864

4.  Multiantigen print immunoassay for comparison of diagnostic antigens for Taenia solium cysticercosis and taeniasis.

Authors:  Sukwan Handali; Molly Klarman; Amanda N Gaspard; John Noh; Yeuk-Mui Lee; Silvia Rodriguez; Armando E Gonzalez; Hector H Garcia; Robert H Gilman; Victor C W Tsang; Patricia P Wilkins
Journal:  Clin Vaccine Immunol       Date:  2009-11-11

5.  Natural history of solitary cerebral cysticercosis cases after albendazole therapy: a longitudinal follow-up study from India.

Authors:  D Goel; M Mittal; K K Bansal; A Singhal
Journal:  Acta Neurol Scand       Date:  2009-11-26       Impact factor: 3.209

6.  Porcine antibody responses to taenia solium antigens rGp50 and sTs18var1.

Authors:  Sukwan Handali; Armando E Gonzalez; Kathy Hancock; Hector H Garcia; Jacquelin M Roberts; Robert H Gilman; Victor C W Tsang
Journal:  Am J Trop Med Hyg       Date:  2004-09       Impact factor: 2.345

7.  Epilepsy and neurocysticercosis in rural Tanzania-An imaging study.

Authors:  Andrea Sylvia Winkler; Joachim Blocher; Herbert Auer; Thaddaeus Gotwald; William Matuja; Erich Schmutzhard
Journal:  Epilepsia       Date:  2008-11-19       Impact factor: 5.864

Review 8.  Imaging findings in neurocysticercosis.

Authors:  Héctor H García; Oscar H Del Brutto
Journal:  Acta Trop       Date:  2003-06       Impact factor: 3.112

9.  Combination therapy with albendazole and praziquantel versus albendazole alone in children with seizures and single lesion neurocysticercosis: a randomized, placebo-controlled double blind trial.

Authors:  Satvinder Kaur; Pratibha Singhi; Sunit Singhi; Niranjan Khandelwal
Journal:  Pediatr Infect Dis J       Date:  2009-05       Impact factor: 2.129

Review 10.  Surgical management of neurocysticercosis.

Authors:  Vedantam Rajshekhar
Journal:  Int J Surg       Date:  2010-01-04       Impact factor: 6.071

View more
  81 in total

1.  Occasional resolution of multiple parenchymal brain calcifications in patients with neurocysticercosis.

Authors:  Luis Jean Pierre Meneses Quiroz; Isidro Gonzales; Edwin Javier Pretell; Herbert Saavedra; Hector H Garcia
Journal:  Neurol Clin Pract       Date:  2015-12

2.  Asymptomatic Giant Intraventricular Cysticercosis: A Case Report.

Authors:  Ornusa Teerasukjinda; Suwarat Wongjittraporn; Chawat Tongma; Heath Chung
Journal:  Hawaii J Med Public Health       Date:  2016-07

3.  Intraventricular Taenia solium cysts presenting with Bruns syndrome and indications for emergent neurosurgery.

Authors:  Lokesh Shahani; Natalie Dailey Garnes; Rojelio Mejia
Journal:  Am J Trop Med Hyg       Date:  2015-04-13       Impact factor: 2.345

4.  Corticosteroid withdrawal precipitates perilesional edema around calcified Taenia solium cysts.

Authors:  Rojelio Mejia; Theodore E Nash
Journal:  Am J Trop Med Hyg       Date:  2013-09-03       Impact factor: 2.345

Review 5.  A comprehensive review of imaging findings in human cysticercosis.

Authors:  Bargavee Venkat; Neeti Aggarwal; Sushma Makhaik; Ramgopal Sood
Journal:  Jpn J Radiol       Date:  2016-02-23       Impact factor: 2.374

Review 6.  Clinical symptoms, diagnosis, and treatment of neurocysticercosis.

Authors:  Hector H Garcia; Theodore E Nash; Oscar H Del Brutto
Journal:  Lancet Neurol       Date:  2014-11-10       Impact factor: 44.182

7.  Neurocysticercosis in the United States.

Authors:  Jose A Serpa; A Clinton White
Journal:  Pathog Glob Health       Date:  2012-09       Impact factor: 2.894

8.  In vitro analysis of albendazole sulfoxide enantiomers shows that (+)-(R)-albendazole sulfoxide is the active enantiomer against Taenia solium.

Authors:  Adriana Paredes; Tiago de Campos Lourenço; Miguel Marzal; Andrea Rivera; Pierre Dorny; Siddhartha Mahanty; Cristina Guerra-Giraldez; Hector H García; Theodore E Nash; Quezia B Cass
Journal:  Antimicrob Agents Chemother       Date:  2012-12-10       Impact factor: 5.191

9.  Quantitative screening for anticestode drugs based on changes in baseline enzyme secretion by Taenia crassiceps.

Authors:  Siddhartha Mahanty; Elise M Madrid; Theodore E Nash
Journal:  Antimicrob Agents Chemother       Date:  2012-12-10       Impact factor: 5.191

10.  Enhanced steroid dosing reduces seizures during antiparasitic treatment for cysticercosis and early after.

Authors:  Hector H Garcia; Isidro Gonzales; Andres G Lescano; Javier A Bustos; E Javier Pretell; Herbert Saavedra; Theodore E Nash
Journal:  Epilepsia       Date:  2014-08-04       Impact factor: 5.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.